As we described at the outset of this review, much is known about molecular mechanisms of CRIPTO signaling especially as it pertains to TGF-β pathway modulation (see Klauzinska et al. [3] for a review), however our knowledge of the mechanisms that connects tumor associated pressures to CRIPTO regulation, signaling and cancer-dependent cellular outputs remains insufficient. The gene discussed is CRIPTO; the disease is neoplasm.